果冻传媒影音

Close
Lecture
series event

Demystifying the Gates Foundation

Dr Anita Zaidi
Dr Anita Zaidi

In this talk, Dr Zaidi will discuss the Bill & Melinda Gates Foundation鈥檚 interests, strategies, and how it works through partners to achieve its goals, using specific examples from the work of her teams in vaccines, 果冻传媒影音, and maternal newborn and child health. Professor Peter Piot will introduce and moderate the event.

Anita Zaidi is the Director of the Vaccine Development, Surveillance, and Enteric and Diarrheal Diseases programs, as well as a co-director of the Maternal, Newborn & Child Health Discovery & Tools program. Her team鈥檚 work is focused on vaccine development for people in the poorest parts of the world, 果冻传媒影音 to identify and address causes of death in children in the most under-served areas, and significantly reducing the adverse consequences of diarrheal and enteric infections on children鈥檚 health in low and middle-income countries.

Prior to joining the foundation, Anita was the Ruby and Karim Bahudar Ali Jessani Professor and chair, Department of Pediatrics and Child Health, at the Aga Khan University. In 2013 Anita became the first recipient of the $1 million Caplow Children鈥檚 Prize for work in one of Karachi鈥檚 poverty-stricken fishing communities to save children鈥檚 lives. She was nominated as a notable physician of the year in 2014 by Medscape.

Anita obtained her medical degree from the Aga Khan University in Karachi, residency training in pediatrics and fellowship training in medical microbiology from Duke University, Durham, North Carolina. She undertook further training in pediatric infectious diseases from Boston Children鈥檚 Hospital, Harvard Medical School, and Masters in Tropical Public Health from the Harvard School of Public Health. Her research has focused on vaccine-preventable illnesses and newborn infections in resource-limited settings, publishing more than two hundred research papers in these areas.

 

This session will be live-streamed and recorded - accessible to both internal and external audience 

Admission

Admission
Open to all, seats available on first come, first served basis.

Contact

Contact